Search Within

Suzanne M Chanel

Formats
  1. Meeting Abstract (21)
  2. Journal Article (10)
Groups
  1. Nursing (31)
  2. Adult Leukemia (24)
  3. Center for Hematologic Malignancies (24)
  4. Department of Medicine (24)
  5. Hematologic Malignancies, Division of (24)
  6. GSK Faculty (17)

More Groups

People
  1. David Scheinberg (16)
  2. Peter Maslak (13)
  3. Joseph Jurcic (10)
  4. Ellin Berman (9)
  5. Steven Soignet (9)
  6. Raymond Warrell (8)

More People

Years
  1. 2019 (1)
  2. 2018 (2)
  3. 2016 (1)
  4. 2013 (1)
  5. 2012 (1)
  6. 2011 (2)

More Years

Publications
  1. Blood (14)
  2. Journal of Clinical Oncology (5)
  3. Leukemia (2)
  4. Blood Advances (1)
  5. Cancer Biotherapy and Radiopharmaceuticals (1)
  6. Clinical Cancer Research (1)

More Publications

Publishers
  1. American Society of Hematology (15)
  2. American Society of Clinical Oncology (5)
  3. American Association for Cancer Research (2)
  4. Nature Publishing Group (2)
  5. BMJ Group (1)
  6. Elsevier Ltd (1)

More Publishers

Results (31)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Rapid-cycle change: An effective strategy to meet an unforeseen practice change within the outpatient chemotherapy infusion setting
    Meeting Abstract

    Italiano, D.; Stinziani, M.; Andronico, J.; Wall, L.; Chanel, S.
    Oncology Nursing Forum (2019)

    Fulltext@MSK | Save
  • Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemia
    Journal Article

    Maslak, P. G.; Dao, T.; Bernal, Y.; Chanel, S. M.; Zhang, R.; Frattini, M.; Rosenblat, T.; Jurcic, J. G.; Brentjens, R. J.; Arcila, M. E.; more...
    Blood Advances (2018)

    Fulltext@MSK | Save
  • Hsp90 inhibition disrupts JAK-STAT signaling and leads to reductions in splenomegaly in patients with myeloproliferative neoplasms
    Journal Article

    Hobbs, G. S.; Hanasoge Somasundara, A. V.; Kleppe, M.; Litvin, R.; Arcila, M.; Ahn, J.; McKenney, A. S.; Knapp, K.; Ptashkin, R.; Weinstein, H.; more...
    Haematologica (2018)

    Fulltext@MSK | Save
  • Phase II trial of WT1 analog peptide vaccine in adults with acute myeloid leukemia (AML) in first complete remission (CR)
    Meeting Abstract

    Maslak, P. G.; Dao, T.; Bernal, Y.; Chanel, S. M.; Zhang, R.; Frattini, M. G.; Rosenblat, T. L.; Jurcic, J. G.; Rampal, R.; Park, J. H.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Effect of long term imatinib on bone in adults with chronic myelogenous leukemia and gastrointestinal stromal tumors
    Journal Article

    Berman, E.; Girotra, M.; Cheng, C.; Chanel, S.; Maki, R.; Shelat, M.; Strauss, H. W.; Fleisher, M.; Heller, G.; Farooki, A.
    Leukemia Research (2013)

    Fulltext@MSK | Save
  • Phase II trial of WT1 analog peptide vaccine in patients with acute myeloid leukemia (AML) in complete remission (CR)
    Meeting Abstract

    Rosenblat, T. L.; Frattini, M. G.; Chanel, S. M.; Dao, T.; Bernal, Y.; Jurcic, J. G.; Zhang, R.; Simancek, P.; Tallman, M. S.; Scheinberg, D. A.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Phase I trial of the targeted alpha-particle nano-generator actinium-225 ((225)Ac-lintuzumab) (anti-CD33; HuM195) in acute myeloid leukemia (AML)
    Meeting Abstract

    Jurcic, J. G.; Rosenblat, T. L.; McDevitt, M. R.; Pandit-Taskar, N.; Carrasquillo, J. A.; Chanel, S. M.; Ryan, C.; Frattini, M. G.; Cicic, D.; Larson, S. M.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase I trial of the targeted alpha-particle nano-generator actinium-225 (ac-225)-lintuzumab (anti-CD33; HuM195) in acute myeloid leukemia (AML)
    Meeting Abstract

    Jurcic, J. G.; Rosenblat, T. L.; McDevitt, M. R.; Pandit-Taskar, N.; Carrasquillo, J. A.; Chanel, S. M.; Zikaras, K.; Frattini, M. G.; Maslak, P. G.; Cicic, D.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Effects of long term imatinib on bone mineral density in patients with chronic myelogenous leukemia (CML) or gastrointestinal stromal tumor (GIST)
    Meeting Abstract

    Berman, E.; Maki, R.; Farooki, A.; Girotra, M.; Chanel, S.; Cheng, C.; Strauss, H. W.; Fleisher, M.
    Blood (2010)

    Fulltext@MSK | Save
  • Sequential cytarabine and α-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemia
    Journal Article

    Rosenblat, T. L.; McDevitt, M. R.; Mulford, D. A.; Pandit-Taskar, N.; Divgi, C. R.; Panageas, K. S.; Heaney, M. L.; Chanel, S.; Morgenstern, A.; Sgouros, G.; more...
    Clinical Cancer Research (2010)

    Fulltext@MSK | Save